| Literature DB >> 30056378 |
Alessandra Buja1, Roberto Toffanin2, Mirko Claus3, Walter Ricciardi4, Gianfranco Damiani4, Vincenzo Baldo1, Mark H Ebell5.
Abstract
OBJECTIVES: Our goal is to conceptualise a clinical governance framework for the effective management of chronic diseases in the primary care setting, which will facilitate a reorganisation of healthcare services that systematically improves their performance.Entities:
Keywords: chronic disease; health system framework; healthcare; primary health care
Mesh:
Year: 2018 PMID: 30056378 PMCID: PMC6067352 DOI: 10.1136/bmjopen-2017-020626
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Framework for primary care management of chronic disease. EBHC, Evidence-based healthcare.
Systematic reviews
| Author, ref. no | Title | Objectives | Inclusion criteria | Main findings |
|
| ||||
| Nieuwlaat R | Interventions for enhancing medication adherence | The primary objective of this review is to assess the effects of interventions intended to enhance patient adherence to prescribed medications for medical conditions, on both medication adherence and clinical outcomes. | We included unconfounded randomised controlled trials (RCTs) of interventions to improve adherence with prescribed medications, measuring both medication adherence and clinical outcome, with at least 80% follow-up of each group studied and, for long-term treatments, at least 6 months follow-up for studies with positive findings at earlier time points. | The present update included 109 new studies, bringing the total number to 182. |
| In the 17 studies of the highest quality, interventions were generally complex with several different ways to try to improve medicine adherence. These frequently included enhanced support from family, peers or allied health professionals such as pharmacists, who often delivered education, counselling or daily treatment support. Only five of these RCTs improved both medicine adherence and clinical outcomes, and no common characteristics for their success could be identified. Overall, even the most effective interventions did not lead to large improvements. | ||||
| Smith SM | Interventions for improving outcomes in patients with multimorbidity in primary care and community settings | To determine the effectiveness of health-service or patient-oriented interventions designed to improve outcomes in people with multimorbidity in primary care and community settings. Multimorbidity was defined as two or more chronic conditions in the same individual. | We considered RCTs, non-randomised clinical trials (NRCTs), controlled before-after studies (CBAs) and interrupted time series analyses (ITS) evaluating interventions to improve outcomes for people with multimorbidity in primary care and community settings. This includes studies where participants can have combinations of any condition or have combinations of prespecified common conditions. The comparison was usual care as delivered in that setting. | Overall, the results regarding the effectiveness of interventions were mixed. There were no clear positive improvements in clinical outcomes, health service use, medication adherence, patient-related health behaviours, health professional behaviours or costs. There were modest improvements in mental health outcomes from seven studies that targeted people with depression, and in functional outcomes from two studies targeting functional difficulties in participants. Overall, the results indicate that it is difficult to improve outcomes for people with multiple conditions. The review suggests that interventions that are designed to target specific risk factors (eg, treatment for depression) or interventions that focus on difficulties that people experience with daily functioning (eg, physiotherapy treatment to improve capacity for physical activity) may be more effective. There is a need for further studies on this topic, particularly involving people with multimorbidity in general across the age ranges. |
| Arditi C | Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and healthcare outcomes | To evaluate the benefits and harms of rehabilitation interventions directed at maintaining, or improving, physical function for older people in long-term care through the review of RCTs cluster RCTs (CRCTs). | We included individual or CRCTs RCTs and NRCTs that evaluated the impact of computer-generated reminders delivered on paper to healthcare professionals on processes and/or outcomes of care. | There is moderate quality evidence that computer-generated reminders delivered on paper to healthcare professionals achieve moderate improvement in process of care. Two characteristics emerged as significant predictors of improvement: providing space on the reminder for a response from the clinician and providing an explanation of the reminder’s content or advice. The heterogeneity of the reminder interventions included in this review also suggests that reminders can improve care in various settings under various conditions. |
| Thomas RE | Interventions to increase influenza vaccination rates of those aged 60 years and older in the community | To assess access, provider, system and societal interventions to increase the uptake of influenza vaccination in people aged 60 years and older in the community. | RCTs of interventions to increase influenza vaccination uptake in people aged 60 years and older. | There are interventions that are effective for increasing community demand for vaccination, enhancing access and improving provider/system response. In particular, effective interventions in this comparison were a letter plus leaflet/postcard compared with a letter, nurses/pharmacists educating plus vaccinating patients, a phone call from a senior, a telephone invitation rather than clinic drop-in, free groceries lottery and nurses educating and vaccinating patients. We were unable to pool trials of postcard/letter/pamphlets, communications tailored to patients, a customised letter/phone call or client-based appraisals, but several trials of these interventions showed they were effective. |
| Krogsbøll LT | General health checks in adults for reducing morbidity and mortality from disease | We aimed to quantify the benefits and harms of general health checks with an emphasis on patient-relevant outcomes such as morbidity and mortality rather than on surrogate outcomes such as blood pressure and serum cholesterol levels. | We included RCTs comparing health checks with no health checks in adults unselected for disease or risk factors. We did not include geriatric trials. We defined health checks as screening general populations for more than one disease or risk factor in more than one organ system. | There was no effect on the risk of death, or on the risk of death due to cardiovascular diseases or cancer. We did not find an effect on the risk of illness but one trial found an increased number of people identified with high blood pressure and high cholesterol, and one trial found an increased number with chronic diseases. One trial reported the total number of new diagnoses per participant and found a 20% increase over 6 years compared with the control group. No trials compared the total number of new prescriptions but two out of four trials found an increased number of people using drugs for high blood pressure. Two out of four trials found that health checks made people feel somewhat healthier, but this result is not reliable. We did not find that health checks had an effect on the number of admissions to hospital, disability, worry, the number of referrals to specialists, additional visits to the physician or absence from work, but most of these outcomes were poorly studied. None of the trials reported on the number of follow-up tests after positive screening results, or the amount of surgery used. With the large number of participants and deaths included, the long follow-up periods used in the trials, and considering that death from cardiovascular diseases and cancer were not reduced, general health checks are unlikely to be beneficial. |
| Archambault PM | Collaborative writing applications in healthcare: effects on professional practice and healthcare outcomes | The objectives of this review were to: (1) assess the effects of the use of CWAs on process (including the behaviour of healthcare professionals) and patient outcomes, (2) critically appraise and summarise current evidence on the use of resources, costs and cost-effectiveness associated with CWAs to improve professional practices and patient outcomes and (3) explore the effects of different CWA features (eg, open vs closed) and different implementation factors (eg, the presence of a moderator) on process and patient outcomes. | We included RCTs, NRCTs, CBAs, ITS studies and repeated measures studies (RMS), in which CWAs were used as an intervention to improve the process of care, patient outcomes or healthcare costs. | We screened 11 993 studies identified from the electronic database searches and 346 studies from grey literature sources. We analysed the full text of 99 studies. None of the studies met the eligibility criteria; two potentially relevant studies are ongoing. |
| We did not identify any studies that measured the effect of CWAs on how healthcare professionals care for their patients. | ||||
| Fiander M | Interventions to increase the use of electronic health information (EHI) by healthcare practitioners to improve clinical practice and patient outcomes | To assess the effects of interventions aimed at improving or increasing healthcare practitioners’ use of EHI on professional practice and patient outcomes. | We included studies that evaluated the effects of interventions to improve or increase the use of EHI by healthcare practitioners on professional practice and patient outcomes. We defined EHI as information accessed on a computer. We defined ‘use’ as logging into EHI. We considered any healthcare practitioner involved in patient care. We included RCTs, NRCTs, and CRCTs, controlled clinical trials (CCTs), ITS and CBAs. The comparisons were: electronic vs printed health information; EHI on different electronic devices (eg, desktop, laptop or tablet computers, etc; cell/mobile phones); EHI via different user interfaces; EHI provided with or without an educational or training component and EHI compared with no other type or source of information. | The results of this review showed that when provided with a combination of EHI and training, practitioners used the information more often. Two studies measured doctors' use of electronic treatment guidelines, but showed that the electronic aspect of the guidelines did not mean that doctors followed the guidelines. This review provided no information on whether more frequent use of EHI translated into improved clinical practice or whether patients were better off when doctors or nurses used health information when treating them. |
| Flodgren G | Tools developed and disseminated by guideline producers to promote the uptake of their guidelines | To evaluate the effectiveness of implementation tools developed and disseminated by guideline producers, which accompany or follow the publication of a CPG, to promote uptake. A secondary objective is to determine which approaches to guideline implementation are most effective. | We included RCTs and CRCTs, CBAs and ITS studies evaluating the effects of guideline implementation tools developed by recognised guideline producers to improve the uptake of their own guidelines. The guideline could target any clinical area. | Two of the four included studies reported on how well healthcare professionals stick to guideline recommendations when providing care to their patients, depending on whether they received a CPG with a tool aimed at improving the use of the CPG, or if they received the CPG only. The results of this review show that healthcare professionals who received a guideline tool together with the CPG on the management of non-specific low back pain or ordering thyroid-function tests probably stick more closely to the recommendations, compared with those who received the CPG only. A guideline tool aimed at improving the use of a guideline, may lead to little or no difference in cost to the health service. |
| Chen CE | Walk-in clinics vs physician offices and emergency rooms for urgent care and chronic disease management | To assess the quality of care and patient satisfaction of walk-in clinics compared with that of traditional physician offices and emergency rooms for people who present with basic medical complaints for either acute or chronic issues. | Study design: RCTs, NRCTs and CBAs. Population: standalone physical clinics not requiring advance appointments or registration, that provided basic medical care without expectation of follow-up. Comparisons: traditional primary care practices or emergency rooms. | Walk-in clinics are growing in popularity around the world, but it is unclear if the medical care provided by walk-in clinics is comparable to that of physicians' offices or emergency rooms. |
| Scott A | The effect of financial incentives on the quality of healthcare provided by primary care physicians (PCPs) | The aim of this review is to examine the effect of changes in the method and level of payment on the quality of care provided by PCPs and to identify: the different types of financial incentives that have improved quality; the characteristics of patient populations for whom quality of care has been improved by financial incentives; the characteristics of PCPs who have responded to financial incentives. | RCTs, CBAs and ITS evaluating the impact of different financial interventions on the quality of care delivered by PCPs. Quality of care was defined as patient-reported outcome measures, clinical behaviours and intermediate clinical and physiological measures. | The use of financial incentives to reward PCPs for improving the quality of primary healthcare services is growing. However, there is insufficient evidence to support or not support the use of financial incentives to improve the quality of primary healthcare. Implementation should proceed with caution and incentive schemes should be more carefully designed before implementation. In addition to basing incentive design more on theory, there is a large literature discussing experiences with these schemes that can be used to draw out a number of lessons that can be learnt and that could be used to influence or modify the design of incentive schemes. More rigorous study designs need to be used to account for the selection of physicians into incentive schemes. The use of instrumental variable techniques should be considered to assist with the identification of treatment effects in the presence of selection bias and other sources of unobserved heterogeneity. In randomised trials, care must be taken in using the correct unit of analysis and more attention should be paid to blinding. Studies should also examine the potential unintended consequences of incentive schemes by having a stronger theoretical basis, including a broader range of outcomes, and conducting more extensive subgroup analysis. Studies should more consistently describe (i) the type of payment scheme at baseline or in the control group, (ii) how payments to medical groups were used and distributed within the groups and (iii) the size of the new payments as a percentage of total revenue. Further research comparing the relative costs and effects of financial incentives with other behaviour change interventions is also required. |
| Young | Home or foster home care vs institutional long-term care for functionally dependent older people | To assess the effects of long-term home or foster home care vs institutional care for functionally dependent older people. | We included RCTs and NRCTs, CBAs and ITS studies complying with the Cochrane Effective Practice and Organisation of Care (EPOC) Group study design criteria and comparing the effects of long-term home care vs institutional care for functionally dependent older people. | There are insufficient high-quality published data to support any particular model of care for functionally dependent older people. Community-based care was not consistently beneficial across all the included studies; there were some data suggesting that community-based care may be associated with improved quality of life and physical function compared with institutional care. However, community alternatives to institutional care may be associated with increased risk of hospitalisation. Future studies should assess healthcare utilisation, perform economic analysis and consider caregiver burden. |
| Nkansah N | Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns | To examine the effect of outpatient pharmacists' non-dispensing roles on patient and health professional outcomes. | RCTs comparing (1) pharmacist services targeted at patients vs services delivered by other health professionals; (2) pharmacist services targeted at patients vs the delivery of no comparable service; (3) pharmacist services targeted at health professionals vs services delivered by other health professionals; (4) pharmacist services targeted at health professionals vs the delivery of no comparable service. | Only one included study compared pharmacist services with other health professional services, hence we are unable to draw conclusions regarding comparisons 1 and 3. Most included studies supported the role of pharmacists in medication/therapeutic management, patient counselling and providing health professional education with the goal of improving patient process of care and clinical outcomes, and of educational outreach visits on physician prescribing patterns. There was great heterogeneity in the types of outcomes measured across all studies. Therefore, a standardised approach to measure and report clinical, humanistic and process outcomes for future randomised controlled studies evaluating the impact of outpatient pharmacists is needed. Heterogeneity in study comparison groups, outcomes and measures makes it challenging to make generalised statements regarding the impact of pharmacists in specific settings, disease states and patient populations. |
| Gonçalves-Bradley DC | Discharge planning from hospital | To assess the effectiveness of planning the discharge of individual patients moving from hospital. | RCTs that compared an individualised discharge plan with routine discharge care that was not tailored to individual participants. Participants were hospital inpatients. | A discharge plan tailored to the individual patient probably brings about a small reduction in hospital length of stay and reduces the risk of readmission to hospital at 3 months follow-up for older people with a medical condition. Discharge planning may lead to increased satisfaction with healthcare for patients and professionals. There is little evidence that discharge planning reduces costs to the health service. |
|
| ||||
| Parmelli | Interventions to increase clinical incident reporting in healthcare | To assess the effects of interventions designed to increase clinical incident reporting in healthcare settings. | RCTs, CBAs and ITS of interventions designed to increase clinical incident reporting in healthcare. | Because of the limitations of the studies it is not possible to draw conclusions for clinical practice. Anyone introducing a system into practice should give careful consideration to conducting an evaluation using a robust design. |
| Ryan R | Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews | To assess the effects of interventions which target healthcare consumers to promote safe and effective medicines use, by synthesising review-level evidence. | We included systematic reviews published on the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects. We identified relevant reviews by hand searching databases from their start dates to March 2012. | Looking across reviews, for most outcomes, medicines self-monitoring and self-management programmes appear generally effective to improve medicines use, adherence, adverse events and clinical outcomes; and to reduce mortality in people self-managing antithrombotic therapy. However, some participants were unable to complete these interventions, suggesting they may not be suitable for everyone. simplified dosing regimens: with positive effects on adherence; interventions involving pharmacists in medicines management, such as medicines reviews (with positive effects on adherence and use, medicines problems and clinical outcomes) and pharmaceutical care services (consultation between pharmacist and patient to resolve medicines problems, develop a care plan and provide follow-up; with positive effects on adherence and knowledge). delayed antibiotic prescriptions: effective to decrease antibiotic use but with mixed effects on clinical outcomes, adverse effects and satisfaction; practical strategies like reminders, cues and/or organisers, reminder packaging and material incentives: with positive, although somewhat mixed effects on adherence; education delivered with self-management skills training, counselling, support, training or enhanced follow-up; information and counselling delivered together or education/information as part of pharmacist-delivered packages of care: with positive effects on adherence, medicines use, clinical outcomes and knowledge, but with mixed effects in some studies; financial incentives: with positive, but mixed, effects on adherence. |
| Patterson SM | Interventions to improve the appropriate use of polypharmacy for older people | This review sought to determine which interventions, alone or in combination, are effective in improving the appropriate use of polypharmacy and reducing medication-related problems in older people. | A range of study designs were eligible. Eligible studies described interventions affecting prescribing aimed at improving appropriate polypharmacy in people aged 65 years of age and older in which a validated measure of appropriateness was used (eg, Beers criteria, Medication Appropriateness Index). | This review examines studies in which healthcare professionals have taken action to make sure that older people are receiving the most effective and safest medication for their illness. Actions taken included providing pharmaceutical care, a service provided by pharmacists that involves identifying, preventing and resolving medication-related problems, as well as promoting the correct use of medications and encouraging health promotion and education. Another strategy was computerised decision support, which involves a programme on the doctor’s computer that helps him/her to select appropriate treatment. |
| Ivers N | Audit and feedback: effects on professional practice and healthcare outcomes | To assess the effects of audit and feedback on the practice of healthcare professionals and patient outcomes and to examine factors that may explain variation in the effectiveness of audit and feedback. | Randomised trials of audit and feedback (defined as a summary of clinical performance over a specified period of time) that reported objectively measured health professional practice or patient outcomes. In the case of multifaceted interventions, only trials in which audit and feedback was considered the core, essential aspect of at least one intervention arm were included. | Audit and feedback generally leads to small but potentially important improvements in professional practice. The effectiveness of audit and feedback seems to depend on baseline performance and how the feedback is provided. Future studies of audit and feedback should directly compare different ways of providing feedback. |
| Gillaizeau F | Computerised advice on drug dosage to improve prescribing practice | To assess whether computerised advice on drug dosage has beneficial effects on patient outcomes compared with routine care (empiric dosing without computer assistance). | We included RCTs, NRCTs, CBAs and ITS of computerised advice on drug dosage. The participants were healthcare professionals responsible for patient care. The outcomes were any objectively measured change in the health of patients resulting from computerised advice (such as therapeutic drug control, clinical improvement, adverse reactions). | Computerised advice for drug dosage can benefit people taking certain drugs compared with empiric dosing (where a dose is chosen based on a doctor’s observations and experience) without computer assistance. When using the computer system, healthcare professionals prescribed appropriately higher doses of the drugs initially for aminoglycoside antibiotics and the correct drug dose was reached more quickly for oral anticoagulants. It significantly decreased thromboembolism (blood clotting) events for anticoagulants and tended to reduce unwanted effects for aminoglycoside antibiotics and antirejection drugs (although not an important difference). It tended to reduce the length of hospital stay compared with routine care with comparable or better cost-effectiveness. There was no evidence of effects on death or clinical side events for insulin (low blood sugar (hypoglycaemia)), anaesthetic agents, antirejection drugs (drugs taken to prevent rejection of a transplanted organ) and antidepressants. |
| Alldred DP | Interventions to optimise prescribing for older people in care homes | The objective of the review was to determine the effect of interventions to optimise overall prescribing for older people living in care homes. | We included RCTs evaluating interventions aimed at optimising prescribing for older people (aged 65 years or older) living in institutionalised care facilities. Studies were included if they measured one or more of the following primary outcomes: adverse drug events; hospital admissions; mortality or secondary outcomes, quality of life (using validated instrument); medication-related problems; medication appropriateness (using validated instrument); medicine costs. | We could not draw robust conclusions from the evidence due to variability in design, interventions, outcomes and results. The interventions implemented in the studies in this review led to the identification and resolution of medication-related problems and improvements in medication appropriateness; however, evidence of a consistent effect on resident-related outcomes was not found. There is a need for high-quality CRCTs testing clinical decision support systems and multidisciplinary interventions that measure well-defined, important resident-related outcomes. |
|
| ||||
| Ballini L | Interventions to reduce waiting times for elective procedures | To assess the effectiveness of interventions aimed at reducing waiting times for elective care, both diagnostic and therapeutic. | We considered RCTs, CBAs and ITS designs that met EPOC minimum criteria and evaluated the effectiveness of any intervention aimed at reducing waiting times for any type of elective procedure. We considered studies reporting one or more of the following outcomes: number or proportion of participants whose waiting times were above or below a specific time threshold, or participants' mean or median waiting times. Comparators could include any type of active intervention or standard practice. | As only a handful of low-quality studies are presently available, we cannot draw any firm conclusions about the effectiveness of the evaluated interventions in reducing waiting times. However, interventions involving the provision of more accessible services (open access or direct booking/referral) show some promise. |
| Shepeprd S | Hospital at home: home-based end-of-life care | To determine if providing home-based end-of-life care reduces the likelihood of dying in hospital and what effect this has on patients' symptoms, quality of life, health service costs and caregivers, compared with inpatient hospital or hospice care. | RCTs, interrupted time series, or controlled before and after studies evaluating the effectiveness of home-based end-of-life care with inpatient hospital or hospice care for people aged 18 years and older. | The evidence included in this review supports the use of home-based end-of-life care programmes for increasing the number of people who will die at home, although the numbers of people admitted to hospital while receiving end-of-life care should be monitored. Future research should systematically assess the impact of home-based end-of-life care on caregivers. |
| Dwamena F | Interventions for providers to promote a patient-centred approach in clinical consultations | To assess the effects of interventions for healthcare providers that aim to promote patient-centred care approaches in clinical consultations. | In the original review, study designs included RCTs, CCTs, CBAs and ITS studies of interventions for healthcare providers that promote patient-centred care in clinical consultations. | Interventions to promote patient-centred care within clinical consultations are effective across studies in transferring patient-centred skills to providers. However, the effects on patient satisfaction, health behaviour and health status are mixed. There is some indication that complex interventions directed at providers and patients that include condition-specific educational materials have beneficial effects on health behaviour and health status, outcomes not assessed in studies reviewed previously. The latter conclusion is tentative at this time and requires more data. The heterogeneity of outcomes, and the use of single item consultation and health behaviour measures limit the strength of the conclusions. |
| In the present update, we were able to limit the studies to RCTs, thus limiting the likelihood of sampling error. | ||||
| This is especially important because the providers who volunteer for studies of patient-centred care methods are likely to be different from the general population of providers. | ||||
|
| ||||
| Légaré F | Interventions for improving the adoption of shared decision making (SDM) by healthcare professionals | To determine the effectiveness of interventions to improve healthcare professionals’ adoption of SDM. | RCTs and NRCTs, CBAs and ITS studies evaluating interventions to improve healthcare professionals' adoption of SDM where the primary outcomes were evaluated using observer-based outcome measures or patient-reported outcome measures. | It is uncertain whether interventions to improve adoption of SDM are effective given the low quality of the evidence. However, any intervention that actively targets patients, healthcare professionals or both, is better than none. Also, interventions targeting patients and healthcare professionals together show more promise than those targeting only one or the other. |
| Stacey | Decision aids for people facing health treatment or screening decisions | To assess the effects of decision aids in people facing treatment or screening decisions. | We included published RCTs comparing decision aids with usual care and/or alternative interventions. For this update, we excluded studies comparing detailed vs simple decision aids. | Compared with usual care across a wide variety of decision contexts, people exposed to decision aids feel more knowledgeable, better informed and clearer about their values, and they probably have a more active role in decision making and more accurate risk perceptions. There is growing evidence that decision aids may improve values-congruent choices. There are no adverse effects on health outcomes or satisfaction. New for this updated is evidence indicating improved knowledge and accurate risk perceptions when decision aids are used either within or in preparation for the consultation. |
| Ciciriello S | Multimedia educational interventions for consumers about prescribed and over-the-counter medications | To assess the effects of multimedia patient education interventions about prescribed and over-the-counter medications in people of all ages, including children and carers. | RCTs and quasi-RCTs of multimedia-based patient education about prescribed or over-the-counter medications in people of all ages, including children and carers, if the intervention had been targeted for their use. | We found that multimedia education programmes about medications are superior to no education or education provided as part of usual clinical care in improving patient knowledge. There was wide variability in the results from the six studies that compared multimedia education with usual care or no education. However, all but one of the six studies favoured multimedia education. We also found that multimedia education is superior to usual care or no education in improving skill levels. The review also suggested that multimedia was at least as effective as other forms of education, including written education or brief education from a health provider. However, these findings were based on a small number of studies, many of which were of low quality. Multimedia education did not improve compliance with medications (ie, the degree to which a patient correctly follows advice about his or her medication) compared with usual care or no education. We could not determine the effect of multimedia education on other outcomes, such as patient satisfaction, self-efficacy (confidence in their ability to perform health-related tasks) and health outcomes. |
| The review findings therefore suggests that multimedia education programmes about medications could be used alongside usual care provided by health providers. There is not enough evidence to recommend it as a replacement for written education or education by a health professional. Multimedia education could be used instead of detailed education given by a health provider when it is not possible or practical for health professionals to provide this service. This review found that there were differences between the types of education provided to the control groups and what results were measured. This limited the ability to summarise results across studies, so most of the conclusions of this review were based on results from a small number of studies. More studies of multimedia educational programmes are needed to make the results of this review more reliable. | ||||
|
| ||||
| Atherton H | Email for clinical communication between patients/caregivers and healthcare professionals | To assess the effects of healthcare professionals and patients using email to communicate with each other, on patient outcomes, health service performance, service efficiency and acceptability. | RCTs, quasi-RCTs, CBAs and ITS studies examining interventions using email to allow patients to communicate clinical concerns to a healthcare professional and receive a reply, and taking the form of (1) unsecured email, (2) secure email or (3) web messaging. All healthcare professionals, patients and caregivers in all settings were considered. | Eight of the trials looked at email compared with standard methods of communication. Where email was compared with standard methods of communication, we found that we could not properly determine what effect email was having on patient/caregiver outcomes, as there were missing data and the results of the different studies varied. For health service use outcomes the situation was the same, but some results seemed to show that an email intervention may lead to an increased number of emails and telephone calls being received by healthcare professionals. |
| One of the trials looked at email counselling compared with telephone counselling. We found that it only looked at patient outcomes, and found few differences between groups. Where there were differences, these showed that telephone counselling leads to greater changes in lifestyle than email counselling. | ||||
| None of the trials measured how email affects healthcare professionals and only one measured whether email can cause harm. All of the trials were biased in some way and when we measured the quality of all of the results we found them to be of low or very low quality. | ||||
| As a result the results of this review should be viewed with caution. | ||||
| The nature of the results means that we cannot make any recommendations for how email might best be used in clinical practice. | ||||
| Flodgren G | Interactive telemedicine (TM): effects on professional practice and healthcare outcomes | To assess the effectiveness, acceptability and costs of interactive TM as an alternative to, or in addition to, usual care (ie, face-to-face care or telephone consultation). | We considered RCTs of interactive TM that involved direct patient-provider interaction and was delivered in addition to, or substituting for, usual care compared with usual care alone, to participants with any clinical condition. We excluded telephone only interventions and wholly automatic self-management TM interventions. | The findings in our review indicate that the use of TM in the management of heart failure appears to lead to similar health outcomes as face-to-face or telephone delivery of care; there is evidence that TM can improve the control of blood glucose in those with diabetes. |
| The cost to a health service, and acceptability by patients and healthcare professionals, is not clear due to limited data reported for these outcomes. The effectiveness of TM may depend on a number of different factors, including those related to the study population, eg, the severity of the condition and the disease trajectory of the participants, the function of the intervention, eg, if it is used for monitoring a chronic condition, or to provide access to diagnostic services, as well as the healthcare provider and healthcare system involved in delivering the intervention. | ||||
| Weeks G | Non-medical prescribing vs medical prescribing for acute and chronic disease management in primary and secondary care | To assess clinical, patient-reported and resource use outcomes of non-medical prescribing for managing acute and chronic health conditions in primary and secondary care settings compared with medical prescribing (usual care). | RCTs, CRCTs, CBAs (with at least two intervention and two control sites) and ITS (with at least three observations before and after the intervention) comparing: (1) non-medical prescribing vs medical prescribing in acute care; (2) non-medical prescribing vs medical prescribing in chronic care; (3) non-medical prescribing vs medical prescribing in secondary care; (4) non-medical prescribing vs medical prescribing in primary | The findings suggest that non-medical prescribers, practising with varying but high levels of prescribing autonomy, in a range of settings, were as effective as usual care medical prescribers. Non-medical prescribers can deliver comparable outcomes for systolic blood pressure, glycated haemoglobin, low-density lipoprotein, medication adherence, patient satisfaction and health-related quality of life. |
| It was difficult to determine the impact of non-medical prescribing compared with medical prescribing for adverse events and resource use outcomes due to the inconsistency and variability in reporting across studies. | ||||
|
| ||||
| Flodgren G | Local opinion leaders: effects on professional practice and healthcare outcomes | To assess the effectiveness of the use of local opinion leaders in improving professional practice and patient outcomes. | Studies eligible for inclusion were RCTs investigating the effectiveness of using opinion leaders to disseminate evidence-based practice and reporting objective measures of professional performance and/or health outcomes. | Opinion leaders alone or in combination with other interventions may successfully promote evidence-based practice, but effectiveness varies both within and between studies. These results are based on heterogeneous studies differing in terms of type of intervention, setting and outcomes measured. In most of the studies, the role of the opinion leader was not clearly described, and it is therefore not possible to say what the best way is to optimise the effectiveness of opinion leaders. |
| Green C J | Pharmaceutical policies: effects of restrictions on reimbursement | To determine the effects of a pharmaceutical policy restricting the reimbursement of selected medications on drug use, healthcare utilisation, health outcomes and costs (expenditures). | Included were studies of pharmaceutical policies that restrict coverage and reimbursement of selected drugs or drug classes, often using additional patient-specific information related to health status or need. We included RCTs, NRCTs, ITS analyses, RMS and CBAs set in large care systems or jurisdictions. | Implementing restrictions to coverage and reimbursement of selected medications can decrease third-party drug spending without increasing the use of other health services (six studies). Relaxing reimbursement rules for drugs used for secondary prevention can also remove barriers to access. Policy design, however, needs to be based on research quantifying the harm and benefit profiles of target and alternative drugs to avoid unwanted health system and health effects. Health impact evaluation should be conducted where drugs are not interchangeable. Impacts on health equity, relating to the fair and just distribution of health benefits in society (eg, sustainable access to publicly financed drug benefits for seniors and low-income populations), also require explicit measurement. |
| Jia L | Strategies for expanding health insurance coverage in vulnerable populations | To assess the effectiveness of strategies for expanding health insurance coverage in vulnerable populations. | RCTs, NRCTs, CBAs and ITS studies that evaluated the effects of strategies on increasing health insurance coverage for vulnerable populations. We defined strategies as measures to improve the enrolment of vulnerable populations into health insurance schemes. Two categories and six specified strategies were identified as the interventions. | Community-based case managers who provide health insurance information, application support and negotiate with the insurer probably increase enrolment of children in health insurance schemes. However, the transferability of this intervention to other populations or other settings is uncertain. Handing out insurance application materials in hospital emergency departments may help increase the enrolment of children in health insurance schemes. Further studies evaluating the effectiveness of different strategies for expanding health insurance coverage in vulnerable population are needed in different settings, with careful attention given to study design. |
|
| ||||
| Reeves S | Interprofessional collaboration (IPC) to improve professional practice and healthcare outcomes | To assess the impact of practice-based interventions designed to improve IPC among healthcare and social care professionals, compared with usual care or to an alternative intervention, on at least one of the following primary outcomes: patient health outcomes, clinical process or efficiency outcomes or secondary outcomes (collaborative behaviour). | We included randomised trials of practice-based IPC interventions involving health and social care professionals compared with usual care or to an alternative intervention. | Given that the certainty of evidence from the included studies was judged to be low to very low, there is not sufficient evidence to draw clear conclusions on the effects of IPC interventions. Nevertheless, due to the difficulties health professionals encounter when collaborating in clinical practice, it is encouraging that research on the number of interventions to improve IPC has increased since this review was last updated. While this field is developing, further rigorous, mixed-method studies are required. Future studies should focus on longer acclimatisation periods before evaluating newly implemented IPC interventions, and use longer follow-up to generate a more informed understanding of the effects of IPC on clinical practice. |
| Smith SM | Shared care across the interface between primary and specialty care in management of long-term conditions | To determine the effectiveness of shared care health service interventions designed to improve the management of chronic disease across the primary/specialty care interface. | We considered RCTs, NRCTs, CBAs and ITS evaluating the effectiveness of shared care interventions for people with chronic conditions in primary care and community settings. The intervention was compared with usual care in that setting. | This review suggests that shared care is effective for managing depression. Shared care interventions for other conditions should be developed within research settings, so that further evidence can be considered before they are introduced routinely into health systems. |
| Hayes SL | Collaboration between local health and local government agencies for health improvement | To evaluate the effects of interagency collaboration between local health and local government agencies on health outcomes in any population or age group. | RCTs, CCTs, CBAs and ITS where the study reported individual health outcomes arising from interagency collaboration between health and local government agencies compared with standard care. Studies were selected independently in duplicate, with no restriction on population subgroup or disease. | Collaboration between local health and local government is commonly considered best practice. However, the review did not identify any reliable evidence that interagency collaboration, compared with standard services, necessarily leads to health improvement. A few studies identified component benefits but these were not reflected in overall outcome scores and could have resulted from the use of significant additional resources. Although agencies appear enthusiastic about collaboration, difficulties in the primary studies and incomplete implementation of initiatives have prevented the development of a strong evidence base. If these weaknesses are addressed in future studies (eg, by providing greater detail on the implementation of programmes; using more robust designs, integrated process evaluations to show how well the partners of the collaboration worked together and measurement of health outcomes), it could provide a better understanding of what might work and why. It is possible that local collaborative partnerships delivering environmental interventions may result in health gain but the evidence base for this is very limited. Evaluations of interagency collaborative arrangements face many challenges. The results demonstrate that collaborative community partnerships can be established to deliver interventions but it is important to agree goals, methods of working, monitoring and evaluation before implementation to protect programme fidelity and increase the potential for effectiveness. |
CPG, clinical practice guideline; CWA, collaborative writing applications.